| Literature DB >> 30036973 |
Haein An1,2, Thinh Dinh Do3, Gila Jung4, Mustafa Zafer Karagozlu5, Chang-Bae Kim6.
Abstract
The crustacean Daphnia pulex is one of the best model organisms for studying inducible defense mechanisms due to their inducible morphology in response to the predator Chaoborus larvae. In this study, multiple developmental stages of D. pulex were exposed to C. flavicans larvae and transcriptome profiles of samples from late embryo to fifth instar were sequenced by the RNA-seq technique to investigate the genetic background underlying inducible defenses. In comparison, differentially expressed genes between defensive and normal morphs were identified, including 908 genes in late embryo, 1383 genes in the first-third (1⁻3) instar, and 1042 genes in fourth-fifth (4⁻5) instar. Gene ontology enrichment analysis showed that structural constituents of the cuticle and structural molecule activity genes were prominent up-regulated genes in late embryos. Down-regulated genes in late embryos and 1⁻3 instar comprised metabolic process, hydrolase activity, and peptidase activity gene classes. Pathway analysis indicated that small molecule neurotransmitter pathways were potentially involved in the development of inducible defenses. The characterization of genes and pathways in multiple developmental stages can improve our understanding of inducible defense responses of D. pulex to predation at the molecular level.Entities:
Keywords: Daphnia pulex; RNA-seq; inducible defenses; multiple developmental stages; neurotransmitter receptor; transcriptome profiles
Mesh:
Substances:
Year: 2018 PMID: 30036973 PMCID: PMC6073494 DOI: 10.3390/ijms19072110
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
The statistics of raw data and trimmed data.
| Libraries | Paired-End Reads Before Trimming | Trimmed Paired-End Reads | Trimmed Single-End Reads | Total Trimmed Reads |
|---|---|---|---|---|
| NML | 49,868,688 | 38,531,810 (77.3%) | 3,480,249 (7.0%) | 42,012,059 (84.2%) |
| NM1–3 | 53,366,508 | 41,745,502 (78.2%) | 3,506,463 (6.6%) | 45,251,965 (84.8%) |
| NM4–5 | 53,291,167 | 42,142,048 (79.1%) | 3,359,151 (6.3%) | 45,501,199 (85.4%) |
| DML | 57,457,116 | 37,663,210 (65.6%) | 4,727,648 (8.2%) | 42,390,858 (73.8%) |
| DM1–3 | 56,210,099 | 37,198,644 (66.2%) | 4,616,768 (8.2%) | 41,815,412 (74.4%) |
| DM4–5 | 57,016,934 | 37,459,438 (65.7%) | 4,689,120 (8.2%) | 42,148,558 (73.9%) |
| Total | 327,210,512 | 234,740,652 (71.7%) | 24,379,399 (7.5%) | 259,120,051 (79.2%) |
NML (normal morph of late embryo), NM1–3 (normal morph of 1–3 instar), NM4–5 (normal morph of 4–5 instar), DML (defensive morph of late embryo), DM1–3 (defensive morph of 1–3 instar), and DM4–5 (defensive morph of 4–5 instar).
Results of mapping reads to the D. pulex genome.
| Libraries | Mapped Reads | Mapped Genes |
|---|---|---|
| NML | 23,508,160 (56.0%) | 16,139 (52.2%) |
| NM 1–3 | 24,761,033 (54.7%) | 16,153 (52.3%) |
| NM 4–5 | 24,143,663 (53.1%) | 16,400 (53.1%) |
| DML | 25,006,291 (59.0%) | 16,112 (52.1%) |
| DM 1–3 | 22,349,587 (53.4%) | 16,284 (52.7%) |
| DM 4–5 | 21,679,668 (51.4%) | 16,427 (53.1%) |
| Total | 141,448,402 (54.6%) | 18,207 (58.9%) |
NML (normal morph of late embryo), NM 1–3 (normal morph of 1–3 instar), NM 4–5 (normal morph of 4–5 instar), DML (defensive morph of late embryo), DM 1–3 (defensive morph of 1–3 instar), and DM 4–5 (defensive morph of 4–5 instar).
Figure 1Number of DEGs (differentially expressed genes) in defensive morph of D. pulex by comparing to normal morph in each developmental stage (A). Diagram (B) shows the number of DEGs shared by late embryo (red), 1–3 instar (green), and 4–5 instar (yellow) stages.
Figure 2GO (Gene Ontology) enrichment analysis (FDR (false discovery rate) < 0.05) for the DEGs (fold change > 2, p < 0.01) in each developmental stage. Red and green represent up-regulated and down-regulated genes in defensive morph, respectively. The x axis shows enriched GO terms and y axis show the percentage of up- and/or down-regulated genes. The percentages of regulated genes were calculated individually for every GO term.
DEGs in glutamatergic pathway.
| Gene ID | Late Embryo | 1–3 Instar | 4–5 Instar | Pathway Genes | Descriptions |
|---|---|---|---|---|---|
| e_gw1.374.3.1 | Up | - | - |
| NMDA receptor subunit GluN2 * |
| NCBI_GNO_10400049 | Up | - | - |
| Inositol 1.4.5- trisphosphate receptor * |
| estExt_fgenesh1_pm.C_140020 | Up | - | - |
| Mitogen-activated protein kinase ** |
| NCBI_GNO_8900043 | Down | - | - |
| Kainate receptor subunit GluR8 * |
| NCBI_GNO_3900088 | - | Up | - |
| AMPA receptor subunit GluR2 * |
| NCBI_GNO_18700035 | - | Up | - |
| Kainate receptor subunit GluR10 * |
| fgenesh1_pg.C_scaffold_183000025 | - | Down | - |
| Kainate receptor subunit GluR5 * |
| NCBI_GNO_2300006 | - | Down | - |
| Kainate receptor subunit GluR7 * |
| PASA_GEN_1700130 | - | Down | - |
| Metabotropic glutamate receptor subunit GRM2 * |
| fgenesh1_pg.C_scaffold_92000012 | - | Down | - |
| SH3 and multiple ankyrin repeat domains protein * |
| fgenesh1_pg.C_scaffold_39000059 | - | Down | - |
| Adenylate cyclase ** |
| estExt_fgenesh1_pg.C_1830028 | - | Down | - |
| Protein kinase A * |
| NCBI_GNO_8300040 | - | - | Up |
| NMDA receptor subunit GRIN1 * |
| estExt_fgenesh1_pg.C_1130025 | - | - | Up |
| NMDA receptor subunit GluN2 * |
| NCBI_GNO_8300009 | - | - | Up |
| Kainate receptor subunit GluR5 * |
| NCBI_GNO_1700146 | - | - | Up |
| Kainate receptor subunit GluR6 * |
| NCBI_GNO_0900239 | - | - | Up |
| Kainate receptor subunit GluR9 * |
| NCBI_GNO_1500242 | - | - | Down |
| Kainate receptor subunit GluR5 * |
Desciptions of DEGs are referred from wFleaBase (*), uniprot (**).
DEGs in cholinergic pathway.
| Gene ID | Late Embryo | 1–3 Instar | 4–5 Instar | Pathway Genes | Descriptions |
|---|---|---|---|---|---|
| estExt_fgenesh1_pm.C_140020 | Up | - | - |
| Mitogen-activated protein kinase ** |
| NCBI_GNO_10400049 | Up | - | - |
| Inositol 1.4.5-trisphosphate receptor * |
| estExt_fgenesh1_pg.C_70190 | Down | Up | - |
| RAS GTPase * |
| fgenesh1_pg.C_scaffold_62000026 | - | Up | - |
| Nicotinic acetylcholine receptor α-8 precursor ** |
| NCBI_GNO_2400096 | - | Up | - |
| RAS GTPase * |
| estExt_fgenesh1_pg.C_1830028 | - | Down | - |
| Protein kinase A * |
| e_gw1.76.84.1 | - | - | Down |
| Nicotinic acetylcholine receptor α-3 ** |
Descriptions of DEGs are referred from wFleaBase (*), uniprot (**).
DEGs in GABA-ergic pathway.
| Gene ID | Late Embryo | 1–3 Instar | 4–5 Instar | Pathway Genes | Descriptions |
|---|---|---|---|---|---|
| fgenesh1_pm.C_scaffold_46000013 | Down | - | Up |
| GABA transaminase * |
| gw1.100.93.1 | Up | - | - |
| GABA transaminase * |
| estExt_Genewise1.C_360108 | - | Up | Up |
| GABA transaminase * |
| estExt_fgenesh1_pg.C_1830028 | - | Down | - |
| Protein kinase A * |
| fgenesh1_pg.C_scaffold_39000059 | - | Down | - |
| Adenylate cyclase ** |
Descriptions of DEGs are referred from wFleaBase (*), uniprot (**).